FDA Brief

Warning letters Devices

FDA warning letter to

Marci Beauty LLC

High riskIssued Feb 2, 2021Posted Oct 5, 2021Center for Devices and Radiological Health

Marci Beauty markets seven light therapy devices without FDA clearance or approval, with claims to treat serious diseases.

What happened

FDA reviewed www.spacetouch.com on February 2, 2021 and found Marci Beauty marketing seven light therapy devices without FDA marketing clearance or approval (FDA’s permission to sell a medical device). FDA said website claims made the products medical devices and included unverified claims to treat serious conditions. FDA also said the firm’s July 23, 2020 response to its June 17, 2020 letter was not adequate because the cited RED Light Device clearance (K162489) did not relate to these devices and had narrower indications.

What FDA found

  1. The firm marketed light therapy devices without an FDA-approved premarket approval (PMA, FDA’s approval to market a device) or an investigational device exemption (IDE, permission to study an unapproved device).

    Section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B); section 515(a), 21 U.S.C. § 360e(a); section 520(g), 21 U.S.C. § 360j(g)
  2. The firm did not notify FDA of its intent to put the devices into commercial distribution, as required for 510(k) review.

    Section 502(o) of the Act, 21 U.S.C. § 352(o); section 510(k), 21 U.S.C. § 360(k)
  3. The firm’s website claims made the products medical devices intended to diagnose, cure, mitigate, treat, or prevent disease or affect body structure or function.

    Section 201(h) of the Act, 21 U.S.C. § 321(h)
  4. The website claimed the devices treat serious conditions such as cancers, dysplasia, jaundice, osteoporosis, heart disease, kidney and digestive tract diseases, emaciation, and anemia without clinical data in an FDA marketing application.

What FDA wants

FDA asks Marci Beauty to stop activities that make the devices misbranded or adulterated, such as selling them for the claimed uses, and to respond in writing within 15 business days with steps taken and plans to prevent recurrence, plus a timetable if fixes will take longer.

Who should pay attention

  • consumers considering home LED light therapy devices
  • retailers and online marketplaces selling beauty light devices
  • brands that import light therapy devices from contract manufacturers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. AseptiKits, LLC

    AseptiKits marketed unapproved sterile-preparation device kits without FDA clearance or approval, FDA says.

    High risk
  2. Happiest Baby, Inc.

    FDA says Happiest Baby marketed unapproved SNOO sleep sacks and hospital bundle and mishandled complaints.

    High risk
  3. Estar Technologies Ltd

    FDA warns Estar Technologies over selling seven unapproved PRP/PRF device kits in the U.S. without clearance or approval.

    High risk
  4. ProDx Health

    FDA warns ProDx Health that its HIV sample self-collection kits are sold without marketing authorization.

    High risk